Correction: The signal pathways and treatment of cytokine storm in COVID-19

Correction: The signal pathways and treatment of cytokine storm in COVID-19

Bibliographic Details
Main Authors:	Lan Yang, Xueru Xie, Zikun Tu, Jinrong Fu, Damo Xu, Yufeng Zhou
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-08-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-021-00744-8

Similar Items

The signal pathways and treatment of cytokine storm in COVID-19
by: Lan Yang, et al.
Published: (2021-07-01)

COVID-19: In the Eye of the Cytokine Storm
by: Roberto de la Rica, et al.
Published: (2020-09-01)

The Management of Cytokine Storm in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2020-10-01)

Controlling Cytokine Storm Is Vital in COVID-19
by: Lu Tang, et al.
Published: (2020-11-01)

Cytokine storm in COVID-19 and the treatment simulacrum
by: Anita Karimi, et al.
Published: (2020-01-01)

Immunotherapy Summary for Cytokine Storm in COVID-19
by: Yaqun Li, et al.
Published: (2021-09-01)

Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
by: Antonella Fara, et al.
Published: (2020-09-01)

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
by: Angela E. Peter, et al.
Published: (2021-01-01)

Candesartan could ameliorate the COVID-19 cytokine storm
by: Abdel G. Elkahloun, et al.
Published: (2020-11-01)

Cytokine storm in COVID-19: Potential therapeutics for immunomodulation
by: Md Mohosin Rana
Published: (2020-09-01)

COVID-19: more than a cytokine storm
by: Giovanni Riva, et al.
Published: (2020-09-01)

A glimpse into the eye of the COVID-19 cytokine storm
by: Krutika Kuppalli, et al.
Published: (2020-05-01)

Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration
by: Ruirong Chen, et al.
Published: (2021-04-01)

Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review
by: Quirch, Miguel, et al.
Published: (2020-08-01)

Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients
by: Hui Guo, et al.
Published: (2020-10-01)

Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms
by: Khan MA, et al.
Published: (2021-01-01)

How COVID-19 induces cytokine storm with high mortality
by: Shintaro Hojyo, et al.
Published: (2020-10-01)

On the role of bacterial metalloproteases in COVID-19 associated cytokine storm
by: László Földvári-Nagy, et al.
Published: (2021-01-01)

Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
by: Luigi Brunetti, et al.
Published: (2020-09-01)

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
by: Yujun Tang, et al.
Published: (2020-07-01)

Cytokine storm in severe patient COVID-19 and curative plasmapheresis
by: Victoria Rusu
Published: (2021-09-01)

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
by: Kenneth E. Remy, et al.
Published: (2021-02-01)

Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19
by: Steven Douedi, et al.
Published: (2020-01-01)

Covid-19 cytokine storm in pulmonary tissue: Anatomopathological and immunohistochemical findings
by: Anna Flavia Ribeiro dos Santos Miggiolaro, et al.
Published: (2020-01-01)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
by: Annette Langer-Gould, et al.
Published: (2020-10-01)

The COVID-19 Cytokine Storm; What We Know So Far
by: Dina Ragab, et al.
Published: (2020-06-01)

Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids
by: Yi Miao, et al.
Published: (2020-06-01)

Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia
by: Yvon Ruch, et al.
Published: (2020-07-01)

Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19
by: Jayanta Talukdar, et al.
Published: (2020-12-01)

Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome
by: Luke Y.C. Chen, et al.
Published: (2021-05-01)

A research update: Significance of cytokine storm and diaphragm in COVID-19
by: Ashwani Mittal, et al.
Published: (2021-01-01)

Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19
by: Wei-Xi Shen, et al.
Published: (2021-05-01)

Distinct Patterns of Blood Cytokines Beyond a Cytokine Storm Predict Mortality in COVID-19
by: Herr C, et al.
Published: (2021-09-01)

Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients
by: Chaofu Wang, et al.
Published: (2020-07-01)

Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women
by: Aleksandra Obuchowska, et al.
Published: (2021-08-01)

Brain dysfunction in COVID‐19 and CAR‐T therapy: cytokine storm‐associated encephalopathy
by: Umberto Pensato, et al.
Published: (2021-04-01)

MECHANISMS OF CYTOKINE STORM DEVELOPMENT IN COVID-19 AND NEW POTENTIAL TARGETS OF PHARMACOTHERAPY
by: V. I. Petrov, et al.
Published: (2021-05-01)

COVID-19: High-JAKing of the Inflammatory “Flight” by Ruxolitinib to Avoid the Cytokine Storm
by: Cirino Botta, et al.
Published: (2021-01-01)

Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?
by: Giovanna Giovinazzo, et al.
Published: (2020-12-01)

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation
by: Pierre Miossec
Published: (2020-08-01)